Takeda Pharmaceutical Co had a revenue of 1.14T in the quarter ending Dec 31, 2024, with -2.71%. This bring the company's revenue in the last twelve months to 4.58T, Decreased 0.72%. In the fiscal year ending Mar 31, 2024, Takeda Pharmaceutical Co had annual revenue of 4.26T with 5.87% growth.